Sera Dividend Paid And Capex Coverage Ratio from 2010 to 2024
| SERA Stock | USD 8.21 0.12 1.44% |
Dividend Paid And Capex Coverage Ratio | First Reported 2010-12-31 | Previous Quarter (212.41) | Current Value (223.03) | Quarterly Volatility 55.95084044 |
Check Sera Prognostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sera Prognostics' main balance sheet or income statement drivers, such as Net Interest Income of 1.7 M, Interest Income of 1.7 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as Price To Sales Ratio of 579, Dividend Yield of 0.0 or PTB Ratio of 2.79. Sera financial statements analysis is a perfect complement when working with Sera Prognostics Valuation or Volatility modules.
Sera | Dividend Paid And Capex Coverage Ratio |
Latest Sera Prognostics' Dividend Paid And Capex Coverage Ratio Growth Pattern
Below is the plot of the Dividend Paid And Capex Coverage Ratio of Sera Prognostics over the last few years. It is Sera Prognostics' Dividend Paid And Capex Coverage Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sera Prognostics' overall financial position and show how it may be relating to other accounts over time.
| Dividend Paid And Capex Coverage Ratio | 10 Years Trend |
|
Dividend Paid And Capex Coverage Ratio |
| Timeline |
Sera Dividend Paid And Capex Coverage Ratio Regression Statistics
| Arithmetic Mean | (159.30) | |
| Coefficient Of Variation | (35.12) | |
| Mean Deviation | 39.56 | |
| Median | (177.28) | |
| Standard Deviation | 55.95 | |
| Sample Variance | 3,130 | |
| Range | 199 | |
| R-Value | 0.27 | |
| Mean Square Error | 3,128 | |
| R-Squared | 0.07 | |
| Significance | 0.33 | |
| Slope | 3.36 | |
| Total Sum of Squares | 43,827 |
Sera Dividend Paid And Capex Coverage Ratio History
About Sera Prognostics Financial Statements
Sera Prognostics stakeholders use historical fundamental indicators, such as Sera Prognostics' Dividend Paid And Capex Coverage Ratio, to determine how well the company is positioned to perform in the future. Although Sera Prognostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sera Prognostics' assets and liabilities are reflected in the revenues and expenses on Sera Prognostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sera Prognostics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (212.41) | (223.03) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:Check out the analysis of Sera Prognostics Correlation against competitors. For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share 0.003 | Quarterly Revenue Growth (0.31) | Return On Assets (0.27) | Return On Equity (0.50) |
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.